ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹5.05 Cr | ₹2.75 Cr | ₹52 Cr | ₹162 Cr | ₹361 Cr |
What is the latest Total Non-Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹5.05 Cr |
Mar2024 | ₹2.75 Cr |
Mar2023 | ₹52 Cr |
Mar2022 | ₹162 Cr |
Mar2021 | ₹361 Cr |
How is Total Non-Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹5.05 Cr | 83.64 | |
Mar2024 | ₹2.75 Cr | -94.75 | |
Mar2023 | ₹52 Cr | -67.66 | |
Mar2022 | ₹162 Cr | -55.13 | |
Mar2021 | ₹361 Cr | - |
Compare Total Non-Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹18,615.1 Cr | -6.2% | -5.5% | -22.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -6% | -7.3% | -12% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -6.2% |
-5.5% |
-22.3% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses